L'effet demeure faible et non significatif pour des doses respectivement 2, 4 et 8 fois plus leves.The effect remains weak and not significant for doses 2, 4 and 8 times higher respectively
Scott Bruner, CEO of the Alliance for Pharmacy Compounding, says Novo Nordisk and Eli Lilly, manufacturers of Wegovy and Zepbound, are amplifying confusion by asserting that they do not sell their active ingredients to compounders, which implies that even legitimate compounders cant safely buy them
Wegovy should be used as part of a specialist weight management service providing multidisciplinary management of obesity, including behavioural, dietary, and exercise interventions
Labs were drawn and sent, and prescriptions were called in that I picked up the same day." "Amazing